General Atlantic Portfolio

Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.

Chi-Med ×

Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.

  • Sector: Healthcare
  • Headquarters: Hong Kong, China
  • Date Invested: 07/02/2020
  • Visit Website

CANbridge ×

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.

  • Sector: Healthcare
  • Headquarters: Beijing, China
  • Date Invested: 03/10/2020
  • Visit Website

Adagene ×

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.

  • Sector: Healthcare
  • Headquarters: Suzhou, China
  • Date Invested: 12/19/2019
  • Visit Website

OcuMension ×

Ocumension is a clinical-stage biotechnology platform company focused on developing and commercializing innovative ophthalmology therapeutics in China.

  • Sector: Healthcare
  • Headquarters: Shanghai, China
  • Date Invested: 06/18/2019

Asia Medical ×

Hong Kong Asia Medical Holding Limited is a leading privately-owned Chinese healthcare services provider and hospital operator specializing in cardiology.

  • Sector: Healthcare
  • Headquarters: Wuhan, Hubei Province, China
  • Date Invested: 08/24/2018
  • Visit Website